# Relative Bioavailability of AR10 Compared to Reference Product

> **NCT02723669** · PHASE1 · COMPLETED · sponsor: **Arbor Pharmaceuticals, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AR10
- **DRUG:** acetylcysteine

## Key facts

- **NCT ID:** NCT02723669
- **Lead sponsor:** Arbor Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02723669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02723669, "Relative Bioavailability of AR10 Compared to Reference Product". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02723669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*